Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Indoleamine and tryptophan 2,3-dioxygenases as important future therapeutic targets
Ana Dolšak, Stanislav Gobec, Matej Sova
Pharmacology & Therapeutics (2020) Vol. 221, pp. 107746-107746
Closed Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy
Luming Yang, Zhaole Chu, Meng Liu, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 127
Glioblastoma Therapy: Past, Present and Future
Elena Obrador, Paz Moreno-Murciano, María Oriol-Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 51
In defence of ferroptosis
Francesca M. Alves, Darius J.R. Lane, Triet Phu Minh Nguyen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Kynurenine emerges from the shadows – Current knowledge on its fate and function
Marta Marszałek‐Grabska, Katarzyna Walczak, Kinga Gaweł, et al.
Pharmacology & Therapeutics (2021) Vol. 225, pp. 107845-107845
Open Access | Times Cited: 96
Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway
Masaru Tanaka, Fanni Tóth, Helga Polyák, et al.
(2021)
Open Access | Times Cited: 92
The role of Platinum(IV)-based antitumor drugs and the anticancer immune response in medicinal inorganic chemistry. A systematic review from 2017 to 2022
Shihao Su, Yutong Chen, Pengfei Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114680-114680
Closed Access | Times Cited: 42
The significant role of amino acid metabolic reprogramming in cancer
Xiaohong Liu, Bo Ren, Jie Ren, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Self‐Carrier Nanoparticles for Delivery of Paclitaxel and IDO Inhibitor to Boost Antitumor Chemo‐Immunotherapy
Zixuan Li, Qing Pei, Min Zhao, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 30
Closed Access | Times Cited: 10
Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO
Minah Kim, Petr Tomek
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 51
A novel prodrug and its nanoformulation suppress cancer stem cells by inducing immunogenic cell death and inhibiting indoleamine 2, 3-dioxygenase
Jiankun Guan, Yuxin Wu, Xin Liu, et al.
Biomaterials (2021) Vol. 279, pp. 121180-121180
Closed Access | Times Cited: 41
Neuroprotective Natural Products’ Regulatory Effects on Depression via Gut–Brain Axis Targeting Tryptophan
Humna Liaqat, Amna Parveen, Sun Yeou Kim
Nutrients (2022) Vol. 14, Iss. 16, pp. 3270-3270
Open Access | Times Cited: 35
Dual-target inhibitors of indoleamine 2, 3 dioxygenase 1 (Ido1): A promising direction in cancer immunotherapy
Ya Zhang, Zelin Hu, Jifa Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114524-114524
Closed Access | Times Cited: 27
Combination of IDO inhibitors and platinum(IV) prodrugs reverses low immune responses to enhance cancer chemotherapy and immunotherapy for osteosarcoma
Dongquan Xiang, Xin-Li Han, Jianxiong Li, et al.
Materials Today Bio (2023) Vol. 20, pp. 100675-100675
Open Access | Times Cited: 19
Neuroactive Kynurenines as Pharmacological Targets: New Experimental Tools and Exciting Therapeutic Opportunities
Ana Pocivavsek, Robert Schwarcz, Sophie Erhardt
Pharmacological Reviews (2024) Vol. 76, Iss. 6, pp. 978-1008
Closed Access | Times Cited: 5
Identification of putative Indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO) dual inhibitors for triple-negative breast cancer therapy
Priyanga Paranthaman, V. Shanthi
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-19
Closed Access
Investigating the role of IDO1 in tumors: correlating IDO1 expression with clinical pathological features and prognosis in lung adenocarcinoma patients
Zhidong Yin, Bohao Sun, Sisi Wang, et al.
PeerJ (2025) Vol. 13, pp. e18776-e18776
Open Access
Apoptotic mesenchymal stem cells and their secreted apoptotic extracellular vesicles: therapeutic applications and mechanisms
Ruoxuan Wang, Jiao Fu, Jing He, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Metabolic Syndrome and Schizophrenia: Adding a Piece to the Interplay Between the Kynurenine Pathway and Inflammation
Jacopo Sapienza, Giulia Agostoni, Federica Repaci, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 176-176
Open Access
Integrating multi-omics data of Triple-Negative Breast Cancer to explore the role of Kynurenine pathway and KYNU as a therapeutic target
Min Lin, J. Zhou, Jun Xiao, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 756, pp. 151569-151569
Closed Access
Immune checkpoint inhibitor-based therapy for advanced clear cell renal cell carcinoma: A narrative review
Yifu Liu, Zhicheng Zhang, Siyuan Wang, et al.
International Immunopharmacology (2022) Vol. 110, pp. 108900-108900
Closed Access | Times Cited: 21
Precision Delivery of Dual Immune Inhibitors Loaded Nanomodulator to Reverse Immune Suppression for Combinational Photothermal‐Immunotherapy
Ying Tian, Muhammad Rizwan Younis, Yatong Zhao, et al.
Small (2023) Vol. 19, Iss. 21
Closed Access | Times Cited: 11
Xanthurenic acid: A role in brain intercellular signaling
Michel Maître, Omar Taleb, Hélène Jeltsch‐David, et al.
Journal of Neurochemistry (2024) Vol. 168, Iss. 9, pp. 2303-2315
Open Access | Times Cited: 3
Oncometabolites in cancer: from cancer cells to the tumor microenvironment
Luoyi Chen, Min Huang
Holistic Integrative Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 3
Redefining Roles: A Paradigm Shift in Tryptophan–Kynurenine Metabolism for Innovative Clinical Applications
Masaru Tanaka, Ágnes Szabó, László Vécsei
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12767-12767
Open Access | Times Cited: 3
Therapeutic potential of targeting kynurenine pathway in neurodegenerative diseases
Hualiang Shen, Xinde Xu, Yalong Bai, et al.
European Journal of Medicinal Chemistry (2023) Vol. 251, pp. 115258-115258
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top